Partnerships & Investors
Partnering to Scale Regenerative Cell Platforms Globally
HanBio is seeking strategic partnerships across biotechnology, clinical development, GMP manufacturing, licensing, regional commercialization, cell banking, cosmetics, and regenerative medicine. The company’s investment materials highlight proprietary DPC, stem cell, and NK cell platforms, revenue-generating cell banking and product lines, GMP infrastructure, patents, and a clinical roadmap led by HXF-101.
